Skip to main content
. Author manuscript; available in PMC: 2009 Nov 25.
Published in final edited form as: Ear Hear. 2009 Apr;30(2):169–177. doi: 10.1097/AUD.0b013e31819342cf

Table 1. Subject demographic information.

Subject Number Sex Age (yr) Age at Implantation (yr) Duration of Implant Use (yr) Implant Device Etiology
1 M 5.8 1.7 4.1 CII Unknown
2 M 7.2 4.3 2.8 CII Congenital
3 F 12.0 10.0 2.0 90K Unknown
4 M 6.3 2.1 4.2 90K Ototoxicity
5 F 9.4 5.8 3.6 CII Unknown
6 F 3.8 2.5 1.3 90K Hyperbilirubinemia
7 F 4.3 2.8 1.5 90K LVAS
8 F 5.4 3.1 2.3 90K Unknown
9 F 7.0 6.1 0.9 90K Ototoxicity
10 M 5.5 2.4 3.1 CII Unknown
11 M 4.1 3.5 0.6 90K Congenital
12 M 11.7 7.5 4.2 CII Ototoxicity
13 M 3.5 2.1 1.4 90K Unknown
14 M 15.8 12.9 2.9 CII Ototoxicity
15 M 16.5 13.5 3.0 CII Ototoxicity
16 M 3.5 2.0 1.5 90K Unknown
17 M 11.9 9.4 2.5 CII Congenital
18 F 4.2 1.3 2.9 CII Unknown
19 F 4.0 3.3 0.7 90K Unknown
20 F 10.8 7.8 3.0 CII Congenital
Mean 7.64 5.21 2.43

LVAS, large vestibular aqueduct syndrome.